Merck Provides Update on Anacetrapib Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/10/2026

1. SPY
2. USO
3. NET
4. ORCL
5. SPCX
6. SAIL
7. SJM
8. ETR
9. AMZN
10. MU

Go back to Merck Provides Update on Anacetrapib Development Program
Merck & Co. (NYSE: MRK) Delayed: 119.09 -0.51 (0.43%)
Previous Close $119.60    52 Week High $65.46 
Open $119.78    52 Week Low $47.97 
Day High $120.04    P/E 81.01 
Day Low $117.26    EPS $1.47 
Volume 10,301,825